InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Lackner Mark. Insider active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €13k. History available since 2 January 2024. The latest transaction was disclosed on 3 February 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Lackner Mark is a declarant linked to Zentalis Pharmaceuticals, Inc. (XNAS), where he is Chief Scientific Officer. He has 4 filings in total, and across the 4 recent filings observed between 2024-01-03 and 2025-02-05, buys are 0 EUR and sells are 13295 EUR, with a transaction nature of Attribution.